Vinit Sudhakar Patil
1, Kedar Rupa Bavaskar
2* , Dilip Omprakash Morani
3, Ashish Suresh Jain
41 Shri D.D. Vispute College of Pharmacy and Research Center, Devad-Vichumbe, New Panvel, India-410206.
2 Department of Pharmaceutics, Shri D.D. Vispute College of Pharmacy and Research Center, Devad-Vichumbe, New Panvel, India-410206.
3 Department of Pharmaceutics, Bombay Institute of Pharmacy and Research, Dombivali India-421204.
4 Department of Pharmacognosy, Shri D.D. Vispute College of Pharmacy and Research Center, Devad-Vichumbe, New Panvel, India-410206.
Abstract
Many people lose their lives to cancer each year. The prevalence of illnesses, metabolic disorders, high-risk infections, and other conditions has been greatly slowed down by expanding scientific research. Chemotherapy and radiation are still the initial lines of treatment for cancer patients, along with surgical removal of tumors. Modifications have been made in chemotherapy since medicines frequently have substantial systemic toxicity and poor pharmacokinetics and still do not reach the tumor site at effective concentrations. Chemotherapy may now be administered more safely and effectively thanks to nanotechnology. Nanotechnology-based graphene quantum dots (GQDs) are very applicable in breast cancer detection, as a drug delivery system, and in the treatment of breast cancer because of their physical and chemical properties, lower toxicity, small size, fluorescence, and effective drug delivery. This paper analyzes the GQDs as cutting-edge platforms for biotechnology and nanomedicine also its application in drug delivery in cancer. It shows that GQDs can be effectively conjugated with hyaluronic acid (HA) to achieve efficient and target-specific delivery.